Bridgefront Capital, LLC Edwards Lifesciences Corp Transaction History
Bridgefront Capital, LLC
- $312 Million
- Q3 2025
A detailed history of Bridgefront Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bridgefront Capital, LLC holds 10,085 shares of EW stock, worth $870,335. This represents 0.25% of its overall portfolio holdings.
Number of Shares
10,085
Previous 20,266
50.24%
Holding current value
$870,335
Previous $1.59 Million
50.54%
% of portfolio
0.25%
Previous 0.45%
Shares
11 transactions
Others Institutions Holding EW
# of Institutions
1,460Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...